662 related articles for article (PubMed ID: 27191990)
41. New Platform for the Direct Profiling of microRNAs in Biofluids.
Detassis S; Grasso M; Tabraue-Chávez M; Marín-Romero A; López-Longarela B; Ilyine H; Ress C; Ceriani S; Erspan M; Maglione A; Díaz-Mochón JJ; Pernagallo S; Denti MA
Anal Chem; 2019 May; 91(9):5874-5880. PubMed ID: 30994325
[TBL] [Abstract][Full Text] [Related]
42. Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer.
Xie H; Chen J; Lv X; Zhang L; Wu J; Ge X; Yang Q; Zhang D; Chen J
Technol Cancer Res Treat; 2020; 19():1533033820947490. PubMed ID: 32851926
[TBL] [Abstract][Full Text] [Related]
43. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC.
Ulivi P; Foschi G; Mengozzi M; Scarpi E; Silvestrini R; Amadori D; Zoli W
Int J Mol Sci; 2013 May; 14(5):10332-42. PubMed ID: 23681013
[TBL] [Abstract][Full Text] [Related]
44. Expression of miR-148/152 family as potential biomarkers in non-small-cell lung cancer.
Li L; Chen YY; Li SQ; Huang C; Qin YZ
Med Sci Monit; 2015 Apr; 21():1155-61. PubMed ID: 25904302
[TBL] [Abstract][Full Text] [Related]
45. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p.
Zhu Y; Li T; Chen G; Yan G; Zhang X; Wan Y; Li Q; Zhu B; Zhuo W
Lung Cancer; 2017 Dec; 114():6-11. PubMed ID: 29173767
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of Serum Paired MicroRNA Ratios for Differential Diagnosis of Non-Small Cell Lung Cancer and Benign Pulmonary Diseases.
Fan L; Sha J; Teng J; Li D; Wang C; Xia Q; Chen H; Su B; Qi H
Mol Diagn Ther; 2018 Aug; 22(4):493-502. PubMed ID: 29922886
[TBL] [Abstract][Full Text] [Related]
47. Circulating miR-21-5p and miR-126-3p: diagnostic, prognostic value, and multivariate analysis in non-small-cell lung cancer.
Soliman SE; Abdelaleem AH; Alhanafy AM; Ibrahem RAL; Elhaded ASA; Assar MFA
Mol Biol Rep; 2021 Mar; 48(3):2543-2552. PubMed ID: 33837901
[TBL] [Abstract][Full Text] [Related]
48. Discovery and validation of extracellular vesicle-associated miRNAs as noninvasive detection biomarkers for early-stage non-small-cell lung cancer.
Zhong Y; Ding X; Bian Y; Wang J; Zhou W; Wang X; Li P; Shen Y; Wang JJ; Li J; Zhang C; Wang C
Mol Oncol; 2021 Sep; 15(9):2439-2452. PubMed ID: 33340250
[TBL] [Abstract][Full Text] [Related]
49. Underexpression of miR-486-5p but not Overexpression of miR-155 is Associated with Lung Cancer Stages.
Mohamed MA; Mohamed EI; El-Kaream SAA; Badawi MI; Darwish SH
Microrna; 2018; 7(2):120-127. PubMed ID: 29437031
[TBL] [Abstract][Full Text] [Related]
50. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
[TBL] [Abstract][Full Text] [Related]
51. A Novel Serum 4-microRNA Signature for Lung Cancer Detection.
Nadal E; Truini A; Nakata A; Lin J; Reddy RM; Chang AC; Ramnath N; Gotoh N; Beer DG; Chen G
Sci Rep; 2015 Jul; 5():12464. PubMed ID: 26202143
[TBL] [Abstract][Full Text] [Related]
52. Identification of reference genes for circulating microRNA analysis in colorectal cancer.
Niu Y; Wu Y; Huang J; Li Q; Kang K; Qu J; Li F; Gou D
Sci Rep; 2016 Oct; 6():35611. PubMed ID: 27759076
[TBL] [Abstract][Full Text] [Related]
53. High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer.
Xu X; Zhu S; Tao Z; Ye S
Cancer Med; 2018 Jan; 7(1):21-31. PubMed ID: 29266846
[TBL] [Abstract][Full Text] [Related]
54. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
55. Circulating Plasma miRNAs as Potential Biomarkers of Non-Small Cell Lung Cancer Obtained by High-Throughput Real-Time PCR Profiling.
Niu Y; Su M; Wu Y; Fu L; Kang K; Li Q; Li L; Hui G; Li F; Gou D
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):327-336. PubMed ID: 30377207
[TBL] [Abstract][Full Text] [Related]
56. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
[TBL] [Abstract][Full Text] [Related]
57. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.
Dong X; Chang M; Song X; Ding S; Xie L; Song X
Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399
[TBL] [Abstract][Full Text] [Related]
58. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
Sun B; Liu HF; Ding Y; Li Z
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
[TBL] [Abstract][Full Text] [Related]
59. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
Tantai J; Hu D; Yang Y; Geng J
Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
[TBL] [Abstract][Full Text] [Related]
60. Serum microRNA biomarkers for detection of non-small cell lung cancer.
Hennessey PT; Sanford T; Choudhary A; Mydlarz WW; Brown D; Adai AT; Ochs MF; Ahrendt SA; Mambo E; Califano JA
PLoS One; 2012; 7(2):e32307. PubMed ID: 22389695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]